TabletsClinical Overview
Faropenem and Potassium Clavulanate is an oral penem antibiotic combined with a beta-lactamase inhibitor. Faropenem exhibits high stability against many bacterial beta-lactamases and binds PBPs with high affinity to block bacterial cell wall synthesis; clavulanic acid broadens this spectrum against ESBL-producing organisms. Indicated for community-acquired respiratory tract infections (sinusitis, bronchitis, pneumonia), complicated urinary tract infections, and resistant skin infections.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Swallow the tablet whole with water, with or after meals to improve tolerance and absorption. Do not crush or chew. Complete the full prescribed course.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Diarrhea, loose stools, nausea, abdominal discomfort, dizziness, and headache. Rare/Severe: Clostridioides difficile colitis, anaphylaxis, liver dysfunction, and severe skin reactions.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in patients with severe allergy to penem or beta-lactam antibiotics. Caution in renal impairment; dose adjustment required. Not recommended in patients with history of carbapenem-related seizures.
Schedule H1 (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Amoxycillin 1g + Potassium Clavulanate 200mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 200mg + Potassium Clavulanate 28.5mg Oral Suspension per 5ml
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 250mg + Potassium Clavulanate 50mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 500mg + Potassium Clavulanate 100mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.